Aurora Cannabis (ACB) Accounts Payables (2018 - 2026)

Aurora Cannabis (ACB) has reported Accounts Payables for 9 consecutive years, with $36.9 million the latest figure, recorded in Q1 2026.

• Quarterly Accounts Payables fell 28.08% year-over-year to $36.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.9 million (down 28.08% YoY) and the FY2026 annual result came in at $36.6 million, down 30.86% from the prior year.
• Accounts Payables retreated to $36.9 million in Q1 2026 per ACB's latest filing, from $48.8 million in the prior quarter.
• Over the last five years, Accounts Payables for ACB reached as high as $74.1 million in Q3 2022 and fell as low as $28.6 million in Q3 2024.
• A 5-year average of $47.2 million and a median of $46.5 million in 2023 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables soared 71.03% — and 2023, when it plunged 48.97%.
• Year by year, Accounts Payables stood at $56.2 million in 2022, then decreased by 18.49% to $45.8 million in 2023, then rose by 9.39% to $50.1 million in 2024, then declined by 2.59% to $48.8 million in 2025, then fell by 24.37% to $36.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $36.9 million, $48.8 million, and $35.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.